» Articles » PMID: 28856536

Interleukin-8 and Nuclear Factor Kappa B Are Increased and Positively Correlated in Myelodysplastic Syndrome

Abstract

The pathogenesis of myelodysplastic syndromes (MDS) is complex and depends on the interaction between aberrant hematopoietic cells and their microenvironment, probably including aberrations in cytokines and their signaling pathways. To evaluate interleukin-8 (IL-8) plasma levels and nuclear factor kappa B (NF-kB) in patients with MDS and to test possible correlation between IL-8 and NF-Kb, a total of 45 individuals were analyzed: 25 consecutive adult de novo MDS patients and 20 sex and age-matched healthy elderly volunteers. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. MDS patients showed higher level of IL-8 when compared to controls (p = 0.006). Patients aged 75 and above showed even higher levels (p = 0.035). NF-kB activity was significantly elevated in MDS patients when compared to controls (p < 0.0001) and higher in patients older than 75 years (p = 0.047). NF-kB activity was associated with higher serum ferritin (p = 0.042) and higher percentage of blasts (p = 0.028). A significant positive correlation between IL-8 and NF-kB was demonstrated (r = 0.480; p = 0.015). Many pathways involved in pathophysiology of MDS have been recently described, suggesting that an inflammatory process may act as a pathogenic driver. In this study, significantly elevated levels of IL-8 and NF-kB were demonstrated in MDS patients, with positive association of NF-kB with some markers of poor prognosis. A positive correlation between IL-8 and NF-kB suggests they cooperate as part of a complex networking of immune and inflammatory factors involved in MDS.

Citing Articles

Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice.

Sampaio L, Dias R, Goes J, de Melo R, de Paula Borges D, de Lima Melo M Med Oncol. 2024; 41(6):128.

PMID: 38656461 DOI: 10.1007/s12032-024-02376-8.


HIF-1α is an important regulator of IL-8 expression in human bone marrow stromal cells under hypoxic microenvironment.

Huang Q, You R, Tan M, Cai D, Zou H, Zhang S Protoplasma. 2023; 261(3):543-551.

PMID: 38135806 DOI: 10.1007/s00709-023-01920-z.


Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review.

Vegivinti C, Keesari P, Veeraballi S, Martins Maia C, Mehta A, Lavu R Exp Hematol Oncol. 2023; 12(1):60.

PMID: 37422676 PMC: 10329313. DOI: 10.1186/s40164-023-00422-1.


Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes.

Paracatu L, Monlish D, Greenberg Z, Fisher D, Walter M, Oh S Exp Hematol. 2022; 110:47-59.

PMID: 35367529 PMC: 9590644. DOI: 10.1016/j.exphem.2022.03.011.


Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review.

Lynch O, Calvi L Cells. 2022; 11(3).

PMID: 35159389 PMC: 8834462. DOI: 10.3390/cells11030580.


References
1.
Singh J, Simoes B, Howell S, Farnie G, Clarke R . Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013; 15(4):210. PMC: 3978717. DOI: 10.1186/bcr3436. View

2.
Banerjee A, Mifsud N, Bird R, Forsyth C, Szer J, Tam C . The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia. Br J Haematol. 2014; 168(4):576-82. DOI: 10.1111/bjh.13151. View

3.
Meyers C, Albitar M, Estey E . Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005; 104(4):788-93. DOI: 10.1002/cncr.21234. View

4.
Kornblau S, McCue D, Singh N, Chen W, Estrov Z, Coombes K . Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010; 116(20):4251-61. PMC: 4081283. DOI: 10.1182/blood-2010-01-262071. View

5.
Belli C, Pinheiro R, Bestach Y, Larripa I, Tanizawa R, Alfonso G . Myelodysplastic syndromes in South America: a multinational study of 1080 patients. Am J Hematol. 2015; 90(10):851-8. DOI: 10.1002/ajh.24097. View